Pharmaceutical insider who defied her three-year prognosis, established a $600M research fund, and tripled patient survival rates brings her patient advocacy expertise to Thyme Care to eliminate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback